Method for producing ergosta5,7-dienol and/or biosynthetic intermediate and/or secondary products thereof in transgenic organisms

Details for Australian Patent Application No. 2004221720 (hide)

Owner BASF Aktiengesellschaft

Inventors Veen, Markus; Lang, Christine; Kunkel, Andreas

Agent Watermark

Pub. Number AU-A-2004221720

PCT Pub. Number WO2004/083407

Priority 103 12 314.8 19.03.03 DE

Filing date 12 March 2004

Wipo publication date 30 September 2004

International Classifications

C12N 001/00 Micro-organisms, e.g. protozoa

C12N 015/52 Mutation or genetic engineering - Genes encoding for enzymes or proenzymes

C12N 015/81 Mutation or genetic engineering - for yeasts

C12N 009/02 Enzymes, e.g. ligases (6.) - Oxidoreductases (1.), e.g. luciferase

C12P 033/00 Preparation of steroids

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/083407 Priority application(s): WO2004/083407

23 August 2007 Assignment before Grant

  BASF Aktiengesellschaft The application has been assigned to OrganoBalance GmbH

7 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004221727-Annular-gap seal for a valve

2004221713-Sanitary insert unit